passages: 1147
passages: document
passages: The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile . A whey protein concentrate prepared from the milk of cows that have been immunized against Clostridium difficile ( C. difficile ) and its toxins , toxin A and toxin B , is produced for use as a medical food for the dietary management of patients with C. difficile-associated diarrhea ( CDAD ) to prevent a relapse of the infection . The safety of anti-C. difficile whey protein concentrate ( anti-CD WPC ) is supported by analytical data comparing the composition of raw milk from immunized cows versus that from non-immunized cows , and the composition of anti-CD WPC versus that of regular whey protein concentrate . Additionally , a prospective clinical study was conducted in 77 patients with CDAD to demonstrate the safety of consuming anti-CD WPC to prevent relapse of the infection . This study , which included adverse event monitoring , physical examinations , and extensive hematological and biochemical assessments , showed that anti-CD WPC is safe to consume by patients with CDAD . The available analytical and clinical evidence demonstrate that anti-CD WPC is safe for use by individuals with CDAD , under the described conditions of use .
entities: 1148
entities: Intervention_Pharmacological
entities: whey protein concentrate
entities: 1149
entities: Intervention_Pharmacological
entities: whey protein concentrate
entities: 1150
entities: Intervention_Pharmacological
entities: immunized against Clostridium difficile ( C.
entities: 1151
entities: Intervention_Pharmacological
entities: anti-C. difficile whey protein concentrate ( anti-CD WPC )
entities: 1152
entities: Intervention_Pharmacological
entities: anti-CD WPC
entities: 1153
entities: Intervention_Pharmacological
entities: regular whey protein concentrate .
entities: 1154
entities: Intervention_Pharmacological
entities: anti-CD WPC
entities: 1155
entities: Intervention_Pharmacological
entities: anti-CD WPC
entities: 1156
entities: Intervention_Pharmacological
entities: anti-CD WPC
entities: 1157
entities: Outcome_Other
entities: safe
entities: 1158
entities: Outcome_Other
entities: safe
entities: 1159
entities: Participant_Condition
entities: patients with C. difficile-associated diarrhea ( CDAD )
entities: 1160
entities: Participant_Sample-size
entities: 77
entities: 1161
entities: Participant_Condition
entities: patients with CDAD
entities: 1162
entities: Participant_Condition
entities: patients with CDAD .
entities: 1163
entities: Participant_Condition
entities: individuals with CDAD